|
PPP4R1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.562700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.476200E-03 |
| Normal-vs-Stage2 |
1.49999999998762E-06 |
| Normal-vs-Stage3 |
1.423890E-03 |
| Normal-vs-Stage4 |
2.394300E-02 |
| Stage1-vs-Stage2 |
2.223200E-04 |
| Stage1-vs-Stage3 |
8.556000E-02 |
| Stage1-vs-Stage4 |
7.848200E-01 |
| Stage2-vs-Stage3 |
7.497500E-02 |
| Stage2-vs-Stage4 |
9.158100E-03 |
| Stage3-vs-Stage4 |
3.623600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.781720E-03 |
| Normal-vs-AfricanAmerican |
5.472100E-02 |
| Normal-vs-Asian |
2.529200E-01 |
| Caucasian-vs-AfricanAmerican |
9.787200E-01 |
| Caucasian-vs-Asian |
1.489040E-01 |
| AfricanAmerican-vs-Asian |
3.591800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.781900E-02 |
| Normal-vs-Female |
1.764480E-04 |
| Male-vs-Female |
4.052800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.292400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.504800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.79820000001385E-07 |
| Normal-vs-Age(81-100Yrs) |
4.221100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.889500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.52127999999419E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.960500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.123600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.054770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.232600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.125800E-02 |
| Classical-VS-Follicular |
3.17168513674915E-12 |
| Classical-VS-Other |
6.142400E-01 |
| Classical-VS-Normal |
6.375500E-02 |
| Tall-VS-Follicular |
3.998700E-03 |
| Tall-VS-Other |
6.906800E-01 |
| Tall-VS-Normal |
1.858960E-03 |
| Follicular-VS-Other |
6.011600E-02 |
| Follicular-VS-Normal |
5.73409997262075E-09 |
| Other-VS-Normal |
2.337000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79930999999467E-05 |
| Normal-vs-N1 |
1.217620E-01 |
| N0-vs-N1 |
2.352000E-02 |
|
|
